Sexually transmitted diseases and infections

Cervical Cancer Market Insight, Epidemiology and Market Forecast, 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, December 11, 2020
Pharmaceutical, Health, Oncology, Gynaecological cancer, Infectious causes of cancer, Sexually transmitted diseases and infections, Carcinogenesis, Cervical cancer, Causes of death, Epidemiology of cancer, Clinical medicine, Cancer, Cervical, Health

The "Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cervical Cancer - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • This 'Cervical Cancer -Market Insights, Epidemiology, and Market Forecast-2030' report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology as well as the market trends of Cervical Cancer in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
  • The Cervical Cancer epidemiology chapters provide insights about historical and current Cervical Cancer patient pool and forecasted trends for every seven major countries.
  • Cervical Cancer epidemiology is segmented by the Incident cases of Cervical Cancer, Stage-specific Incidence of Cervical Cancer, Histopathologic Types of Cervical Cancer, Age-specific cases of Cervical Cancer.

Global Mycoplasma Testing Markets, 2020-2025 - Globalization of Clinical Trials and R&D and Harmonization of Regulations Resulting in Increased Outsourcing

Retrieved on: 
Monday, December 7, 2020
Mollicutes, Sexually transmitted diseases and infections, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Natural sciences, Assay, Taxa

The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.

Key Points: 
  • The global mycoplasma testing industry's growth is driven by factors such as the growing concerns over cell culture contamination, growth in the pharmaceutical and biotechnology industries, and rising pharmaceutical R & D activities and investments.
  • The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period.

Daré Bioscience Announces Positive Topline Results From DARE-BVFREE, a Phase 3 Trial of DARE-BV1 in Patients Diagnosed with Bacterial Vaginosis

Retrieved on: 
Monday, December 7, 2020
Medical specialties, Sexually transmitted diseases and infections, Health, Amphetamine, Bariatrics, Body shape, Nutrition, Obesity, Bacterial vaginosis, Adverse event, Clinical medicine

The DARE-BVFREE studys two treatment arms were well balanced in terms of age, race, ethnicity, bacterial vaginosis history, and body mass index (BMI).

Key Points: 
  • The DARE-BVFREE studys two treatment arms were well balanced in terms of age, race, ethnicity, bacterial vaginosis history, and body mass index (BMI).
  • Over 53% of the ITT population qualified as obese (BMI 30.0), with a mean BMI of 31.50 (standard deviation 8.499).
  • There were no early discontinuations due to adverse events (AEs), and the only serious AE occurred in a woman in the placebo group.
  • DARE-BV1 received both Fast Track and Qualified Infectious Disease Product (QIDP) designations from the FDA for the treatment of bacterial vaginosis.

Global Herpes Treatment Market to Grow by $ 677 Million During 2020-2024 | Highlights Key Segments and Regions of Growth | Technavio

Retrieved on: 
Friday, December 4, 2020
Health, Pharmaceutical, Medical specialties, Virology, Viral diseases, Sexually transmitted diseases and infections, Chickenpox, Biology of bipolar disorder, Herpes simplex, Shingles, Herpes, Neonatal herpes simplex

This is due to the rising prevalence rate of herpes zoster and expected drug launches for the treatment of the condition.

Key Points: 
  • This is due to the rising prevalence rate of herpes zoster and expected drug launches for the treatment of the condition.
  • Also, factors such as the rising number of immunocompromised people and the increasing older population are contributing to the growth of the segment.
  • Factors such as the high prevalence rate of herpes infection, increased awareness, and entry of new players are fostering the growth of the herpes treatment market in Asia.
  • Market growth in this region will be faster than the growth of the market in other regions.

DGAP-News: AiCuris received approval from BfArM to initiate Compassionate Use Program for Pritelivir in Germany

Retrieved on: 
Wednesday, December 2, 2020
Medical specialties, Sexually transmitted diseases and infections, Viral diseases, Purines, Virology, Clinical medicine, Aciclovir, Herpes simplex, Expanded access, Pritelivir, HSV, Compassionate Use Program (CPU), AiCuris Anti-infective Cures GmbH

"Especially in immunocompromised patients, HSV can lead to serious complications," said Dr. Holger Zimmermann, CEO of AiCuris.

Key Points: 
  • "Especially in immunocompromised patients, HSV can lead to serious complications," said Dr. Holger Zimmermann, CEO of AiCuris.
  • At the same time, the data collected in this program will help to bring the drug to patients as quickly as possible and support the planned approval of pritelivir."
  • The Compassionate Use Program in Germany is part of an Early Access Program (EAP) which is operated by myTomorrows, a Netherlands-based HealthTech company facilitating access to medicines in development and real-world data collection.
  • The EAP for treatment of acyclovir-resistant mucocutaneous HSV infections provides immunocompromised patients in different countries worldwide with pre-approval access to pritelivir.

Mycoplasma Testing Market by Product & Service, Technique, Application, End User, Region - Global Forecast to 2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 1, 2020
Other Science, Science, Life sciences, Natural sciences, Sexually transmitted diseases and infections, Biotechnology, Infectious causes of cancer, Bacterial vaginosis, Infertility, Mycoplasma, Mycoplasmataceae, Assay, Biopharmaceutical

The "Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Mycoplasma Testing Market by Product & Service (Assays, Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
  • The assays, kits, & reagents segment accounted for the highest growth rate in the mycoplasma testing market, by product, during the forecast period
    The mycoplasma testing market is segmented into assays, kits, & reagents; instruments; and services based on product & service.
  • Based on application, the mycoplasma testing market is segmented into cell line testing, virus testing, and end-of-production cell testing.
  • The Asia Pacific mycoplasma testing market is estimated to grow at the highest CAGR during the forecast period.

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024: Focus on Immunoassay & Molecular Diagnostic Tests - ResearchAndMarkets.com

Retrieved on: 
Monday, November 30, 2020
Health, General Health, Sexually transmitted diseases and infections, HIV/AIDS, HIV, Lentiviruses, Medical specialties

The "Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024" report has been added to ResearchAndMarkets.com's offering.
  • The HIV rapid test kits market is poised to grow by $ 226.64 mn during 2020-2024 progressing at a CAGR of 6% during the forecast period.
  • This study identifies availability of a broad range of HIV rapid test kits by vendors as one of the prime reasons driving the HIV rapid test kits market growth during the next few years.
  • Also, the HIV rapid test kits market analysis report includes information on upcoming trends and challenges that will influence market growth.

Discovery of a potential treatment against antibiotic-resistant bacteria causing gonorrhea and meningitis

Retrieved on: 
Tuesday, November 24, 2020
Infectious causes of cancer, Neisseriales, Sexually transmitted diseases and infections, Medical specialties, Clinical medicine, Gram-negative bacteria, Pathogenic bacteria, Bacteriology, Neisseria gonorrhoeae, Neisseria, Gonorrhea, Meningitis

This concern is particularly true in the case of Neisseria gonorrhoeae, for which some strains have developed resistance to all effective antibiotics.

Key Points: 
  • This concern is particularly true in the case of Neisseria gonorrhoeae, for which some strains have developed resistance to all effective antibiotics.
  • This bacterium is responsible for gonorrhea, an infection whose incidence has almost tripled in the last decade in Canada.
  • Unlike other bacteria, Neisseria that cause meningitis and gonorrhea evolve very rapidly because of certain intrinsic properties.
  • In parallel, the team wishes to identify an industrial partner to evaluate the possibility of developing a potential treatment.

The Syphilis Testing Market - Abbott Laboratories, Becton, Dickinson and Co., among others to contribute to the market growth | Industry Analysis, Market Trends, Opportunities and Forecast 2020-2024

Retrieved on: 
Friday, November 20, 2020
Infectious diseases, Other Health, Health, Pharmaceutical, Managed care, Articles, Business process, Medical specialties, Infectious diseases, Sexually transmitted diseases and infections, Infections with a predominantly sexual mode of transmission, Spirochaetes, Syphilis, Market research, Market analysis

The syphilis testing market is poised to grow by $0.42 bn during 2020-2024, progressing at a CAGR of over 2% during the forecast period.

Key Points: 
  • The syphilis testing market is poised to grow by $0.42 bn during 2020-2024, progressing at a CAGR of over 2% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201119006033/en/
    Technavio has announced its latest market research report titled Global Syphilis Testing Market 2020-2024 (Graphic: Business Wire)
    The report on the syphilis testing market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The syphilis testing market analysis includes technology segment and geography landscape.
  • This study identifies the expansion of the global syphilis testing due to growing awareness programs as one of the prime reasons driving the syphilis testing market growth during the next few years.

Global HIV Rapid Test Kits Market | Growing Demand For Point-of-care Testing For HIV to Boost the Market Growth | Technavio

Retrieved on: 
Thursday, November 19, 2020
Health, Medical Supplies, Medical devices, HIV/AIDS, Sexually transmitted diseases and infections, Medical specialties, HIV, Lentiviruses, Diagnosis of HIV/AIDS, HIV/AIDS in Rwanda

View the full release here: https://www.businesswire.com/news/home/20201119005824/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20201119005824/en/
    Technavio has announced its latest market research report titled Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2020-2024 (Graphic: Business Wire)
    The global human immunodeficiency virus (HIV) rapid test kits market size is driven by the growing demand for point-of-care testing for HIV.
  • The growing demand for point-of-care testing for HIV will thus drive the demand for HIV rapid test kits over the next five years.
  • As the business impact of COVID-19 spreads, the global HIV rapid test kits market 2020-2024 is expected to have neutral growth.
  • Thus, the presence of a broad range of HIV rapid test kits will increase the adoption of HIV rapid test kits in the coming years.